| Year |
Citation |
Score |
| 2020 |
Chakraborty S, Begg CB, Shen R. Using the "Hidden" genome to improve classification of cancer types. Biometrics. PMID 32914442 DOI: 10.1111/biom.13367 |
0.301 |
|
| 2019 |
Razavi P, Li BT, Brown DN, Jung B, Hubbell E, Shen R, Abida W, Juluru K, De Bruijn I, Hou C, Venn O, Lim R, Anand A, Maddala T, Gnerre S, et al. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Nature Medicine. PMID 31768066 DOI: 10.1038/S41591-019-0652-7 |
0.308 |
|
| 2019 |
Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature Genetics. PMID 30643254 DOI: 10.1038/S41588-018-0312-8 |
0.351 |
|
| 2018 |
Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman DI, Tarpey P, Danilova L, Drill E, Gibb EA, Bowlby R, Kanchi R, Osmanbeyoglu HU, Sekido Y, Takeshita J, ... ... Shen R, et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. PMID 30322867 DOI: 10.1158/2159-8290.Cd-18-0804 |
0.31 |
|
| 2018 |
Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, Cai Y, Bielski CM, Donoghue MTA, Jonsson P, Penson A, Shen R, Pareja F, Kundra R, Middha S, et al. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. Cancer Cell. 34: 427-438.e6. PMID 30205045 DOI: 10.1016/J.Ccell.2018.08.008 |
0.32 |
|
| 2018 |
Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, et al. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018779777. PMID 29989854 DOI: 10.1200/Jco.2018.77.9777 |
0.302 |
|
| 2017 |
Chang MT, Penson AV, Desai NB, Socci ND, Shen R, Seshan V, Kundra R, Abeshouse AA, Viale A, Cha EK, Hao X, Reuter V, Rudin CM, Bochner BH, Rosenberg JE, et al. Small cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29180607 DOI: 10.1158/1078-0432.CCR-17-2655 |
0.342 |
|
| 2017 |
Paik PK, Shen R, Berger MF, Ferry D, Soria JC, Mathewson A, Rooney C, Smith NR, Cullberg M, Kilgour E, Landers D, Frewer P, Brooks AN, André F. A Phase 1b Open Label Multicentre Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28615371 DOI: 10.1158/1078-0432.CCR-17-0645 |
0.355 |
|
| 2017 |
Razavi P, Li BT, Abida W, Aravanis A, Jung B, Shen R, Hou C, De Bruijn I, Gnerre S, Lim RS, Reales D, Maddala T, Berger MF, Riely GJ, Scher HI, et al. Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer. Journal of Clinical Oncology. 35: LBA11516-LBA11516. DOI: 10.1200/Jco.2017.35.15_Suppl.Lba11516 |
0.324 |
|
| 2017 |
Razavi P, Li BT, Hou C, Shen R, Venn O, Lim RS, Hubbell E, De Bruijn I, Liu Q, Vijaya Satya R, Xu H, Shen L, Sehnert A, Maddala T, Berger MF, et al. Cell-free DNA (cfDNA) mutations from clonal hematopoiesis: Implications for interpretation of liquid biopsy tests. Journal of Clinical Oncology. 35: 11526-11526. DOI: 10.1200/Jco.2017.35.15_Suppl.11526 |
0.323 |
|
| 2016 |
Casuscelli J, Wang P, Redzematovic A, Lee W, Seshan VE, Shen R, Donin N, Chen Y, Cheville JC, Pantuck AJ, Thompson RH, Coleman JA, Russo P, Reuter VE, Tickoo S, et al. Understanding the genomic underpinnings of metastatic chromophobe renal cell carcinoma. Journal of Clinical Oncology. 34: 513-513. DOI: 10.1200/Jco.2016.34.2_Suppl.513 |
0.346 |
|
| 2015 |
Grisham RN, Sylvester BE, Won H, McDermott G, DeLair D, Ramirez R, Yao Z, Shen R, Dao F, Bogomolniy F, Makker V, Sala E, Soumerai TE, Hyman DM, Socci ND, et al. Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26324360 DOI: 10.1200/JCO.2015.62.4726 |
0.308 |
|
| 2014 |
Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ. Genomic investigation of etiologic heterogeneity: methodologic challenges. Bmc Medical Research Methodology. 14: 138. PMID 25532962 DOI: 10.1186/1471-2288-14-138 |
0.328 |
|
| 2013 |
Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proceedings of the National Academy of Sciences of the United States of America. 110: 4245-50. PMID 23431203 DOI: 10.1073/Pnas.1208949110 |
0.347 |
|
| 2012 |
Shen R, Mo Q, Schultz N, Seshan VE, Olshen AB, Huse J, Ladanyi M, Sander C. Integrative subtype discovery in glioblastoma using iCluster. Plos One. 7: e35236. PMID 22539962 DOI: 10.1371/Journal.Pone.0035236 |
0.31 |
|
| 2007 |
Yu J, Cao Q, Mehra R, Laxman B, Yu J, Tomlins SA, Creighton CJ, Dhanasekaran SM, Shen R, Chen G, Morris DS, Marquez VE, Shah RB, Ghosh D, Varambally S, et al. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell. 12: 419-31. PMID 17996646 DOI: 10.1016/J.Ccr.2007.10.016 |
0.303 |
|
| 2007 |
Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Research. 67: 7991-5. PMID 17804708 DOI: 10.1158/0008-5472.Can-07-2043 |
0.354 |
|
| 2007 |
Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, Shah RB. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 538-44. PMID 17334343 DOI: 10.1038/Modpathol.3800769 |
0.31 |
|
| 2005 |
Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Research. 65: 11259-64. PMID 16357129 DOI: 10.1158/0008-5472.Can-05-2495 |
0.307 |
|
| 2004 |
Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, Macvicar GR, Varambally S, Harwood J, Bismar TA, Kim R, Rubin MA, Pienta KJ. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Research. 64: 9209-16. PMID 15604294 DOI: 10.1158/0008-5472.Can-04-2442 |
0.312 |
|
| Show low-probability matches. |